secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0001193125-25-162584
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology declares one-time CVR dividend; record date July 24, 2025
------------------------------------------------------------------------

- Board approved one contingent value right (CVR) per share of IKNA common stock.
- Shareholders of record as of July 24, 2025 will receive one CVR per share.
- CVRs entitle holders to net proceeds from sales of pre-Merger assets, including IK-595.
- Proceeds subject to deductions for taxes, expenses, and wind-down costs.
- No assurance any CVR payments will be received; CVRs may have no value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525162584/0001193125-25-162584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525162584/d27352d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-162584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer